Article info

Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations

Authors

  1. Correspondence to Dr Roger Abramino Levy; roger.x.levy{at}gsk.com
View Full Text

Citation

Askanase AD, Furie RA, Dall'Era M, et al
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations

Publication history

  • Received December 4, 2023
  • Accepted April 29, 2024
  • First published May 22, 2024.
Online issue publication 
May 22, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.